News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
Roche’s Tamiflu Gets EU Approval For Use On Children
January 31, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Tamiflu, the anti-influenza drug being stockpiled around the world as a potential defence against bird flu, has received approval to be used for children aged one to twelve in the European Union.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Europe
Roche
MORE ON THIS TOPIC
FDA
Pazdur Questions Safety, Legality of FDA’s Expedited Drug Approval Programs
November 25, 2025
·
2 min read
·
Tristan Manalac
Regulatory
FDA Frictions Continue as White House Denies Promotion to Makary’s Aide
November 24, 2025
·
2 min read
·
Tristan Manalac
Rare diseases
FDA Probing Patient Death Linked to Takeda’s Enzyme Replacement Therapy
November 21, 2025
·
1 min read
·
Dan Samorodnitsky
Regulatory
6 Biotechs With a Shot at the FDA’s Platform Technology Designation
November 21, 2025
·
9 min read
·
Tristan Manalac